くすりのしおり

Injection
Published: 8/2014

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
Gemcitabine I.V. Drip Infusion 1g "Nichiiko"
 Active ingredient:
Gemcitabine hydrochloride
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine inhibits DNA synthesis of cancer cells to suppress proliferation of cancer cells.
It is usually used to treat non-small-cell-lung cancer, pancreatic cancer, biliary tract cancer, urothelial carcinoma, inoperable/recurrence breast cancer, ovarian cancer exacerbated after cancer chemotherapy and recurrence/intractable malignant lymphoma.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have myelosuppression, interstitial pneumonia, pulmonary fibrosis or infection.
    If you are undergoing radiation therapy of chest.
  • If you are pregnant, possibly pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, inject by intravenous infusion.
  • The interval of injection may be decided according to concomitant drugs and symptoms of the patient. Ask the doctor for the detailed schedule.

Precautions while taking this medicine

  • This medicine may cause drowsiness. Avoid driving a car etc. until you are sure that such symptoms do not appear.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include loss of appetite, nausea/vomiting, rash, fatigueness, fever, dysesthesia and hair loss. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • anemia symptoms, fever, bleeding tendency [myelosuppression]
  • respiratory distress, cough, fever [interstitial pneumonia]
  • respiratory distress, decreased blood pressure, rash [anaphylaxis]
  • acute feeling of pressure in the chest, anginal pain, cold sweat [myocardial infarction]
  • respiratory distress, fatigueness, edema of lims [congestive heart failure]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.